MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 212 filers reported holding MEDICINES CO in Q4 2017. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $42,988,000 | -0.5% | 506,100 | -41.4% | 2.38% | -14.2% |
Q3 2019 | $43,190,000 | +136.4% | 863,800 | +72.4% | 2.77% | +164.2% |
Q2 2019 | $18,269,000 | +2543.8% | 501,000 | +1928.3% | 1.05% | +2461.0% |
Q1 2019 | $691,000 | -2.1% | 24,700 | -33.0% | 0.04% | -14.6% |
Q4 2018 | $706,000 | -64.1% | 36,879 | -43.9% | 0.05% | -42.9% |
Q3 2018 | $1,965,000 | +5.6% | 65,700 | +29.6% | 0.08% | -3.4% |
Q2 2018 | $1,861,000 | +41.3% | 50,700 | +26.8% | 0.09% | +33.8% |
Q1 2018 | $1,317,000 | +60.6% | 40,000 | +33.3% | 0.06% | +62.5% |
Q4 2017 | $820,000 | +52.4% | 30,000 | +172.7% | 0.04% | +25.0% |
Q1 2017 | $538,000 | +427.5% | 11,000 | +266.7% | 0.03% | +433.3% |
Q4 2016 | $102,000 | -66.2% | 3,000 | -62.5% | 0.01% | -60.0% |
Q3 2016 | $302,000 | -56.6% | 8,000 | -61.4% | 0.02% | -68.1% |
Q2 2016 | $696,000 | +39.5% | 20,700 | +31.8% | 0.05% | +51.6% |
Q1 2016 | $499,000 | +33.8% | 15,700 | +57.0% | 0.03% | +40.9% |
Q4 2015 | $373,000 | +292.6% | 10,000 | +300.0% | 0.02% | +266.7% |
Q3 2015 | $95,000 | – | 2,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,778,742 | $105,616,000 | 23.17% |
Sarissa Capital Management LP | 3,636,000 | $101,626,000 | 15.30% |
BRIDGER MANAGEMENT, LLC | 2,841,761 | $79,427,000 | 6.29% |
HighVista Strategies LLC | 234,340 | $6,550,000 | 5.34% |
Slate Path Capital LP | 2,170,000 | $60,652,000 | 4.91% |
Camber Capital Management LP | 2,471,523 | $69,079,000 | 3.44% |
Antipodean Advisors LLC | 170,000 | $4,752,000 | 3.38% |
Parian Global Management LP | 152,400 | $4,260,000 | 2.96% |
DLD Asset Management, LP | 2,334,800 | $65,258,000 | 2.40% |
Boxer Capital, LLC | 600,000 | $16,770,000 | 1.94% |